A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment History
The Bond King's departure had a small impact on CEF performance compared with the onslaught in the commodities market.
Appears to be priced in, for now.
A look at ownership data can provide a more detailed look at what mutual funds and institutional players are buying and selling.
Despite the market's wild ride, most CEFs closed the year with positive share price and NAV returns.
When it comes to expenses, CEFs are quite different than open-end mutual funds.
We saw some big trend reversals in 2012's fund launches.
Morningstar's Steve Pikelny discusses his closed-end fund ideas for international fixed-income and equity exposure and the advantages for using CEFs in these areas.